Med. praxi. 2022;19(5):358-361 | DOI: 10.36290/med.2022.055

Skin care of patients undergoing radiotherapy

Mgr. Lenka Krupová, Ph.D.1, doc. MUDr. Ing. Jakub Cvek, Ph.D.2
1 Kožní oddělení, FN Ostrava
2 Klinika onkologická LF OU a FN Ostrava

Radiation dermatitis is a very common reaction in radiotherapy, affecting approximately 95 % of patients with varying intensity. In severe cases, it can significantly impact the quality of life. Appropriate use of clinically proven products protects the patient's skin and achieves excellent results during the treatment of skin reactions. General practitioners can significantly contribute to meeting patients' needs, reassuring them, supporting them, educating them, or supplementing information. Existing GP relationships with their patients are a good precondition for them to be able to inquire and advise without fear. Knowledge of current procedures will help provide consistent information for the patients and their education and recognize when to solve problems and when to recommend the patient to a specialist. The review article is a reduced version of the document Recommendation for preventive and therapeutic skin care of patients undergoing radiotherapy focused on the needs of primary care physicians.

Keywords: radiodermatitida, doporučení, péče o kůži, prevence.radiodermatitis, recommendation, skin care, prevention.

Accepted: November 22, 2022; Published: November 29, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Krupová L, Cvek J. Skin care of patients undergoing radiotherapy. Med. praxi. 2022;19(5):358-361. doi: 10.36290/med.2022.055.
Download citation

References

  1. Cvek J, Vokurka S, Fukasová Hajnová E, et al. Doporučení pro preventivní a léčebnou péči o kůži pacientů podstupujících radioterapii. Klinická Onkologie. 2021;34(6). Go to original source... Go to PubMed...
  2. Šáteková L. Vybrané kapitoly z ošetřovatelství v onkologii. Olomouc: Univerzita Palackého v Olomouci; 2019. DOI: 10.5507/fzv.19.24456300. Go to original source...
  3. Cox JD, Stetz JA, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC). International Journal of Radiation Oncology*Biology*Physics. 1995;31(5):1341-1346. Go to PubMed...
  4. Bolderston A, Cashell A, McQuestion M, et al. A Canadian Survey of the Management of Radiation­‑Induced Skin Reactions. Journal of Medical Imaging and Radiation Sciences. 2018;49(2):164-172. Go to original source... Go to PubMed...
  5. Gee A, Moffitt D, Churn M, et al. A randomised controlled trial to test a non­‑metallic deodorant used during a course of radiotherapy. Journal of Radiotherapy in Practice. 2000;1(4):205-212. Go to original source...
  6. Vorlíček J, Abrahámová J, Vorlíčková H. Klinická onkologie pro sestry. Praha: Grada; 2012.
  7. Johnson K, Fenton G, White RJ. Radiation dermatitis: the evaluation of a new topical therapy for the treatment and prevention of radiation­‑induced skin damage and moist desquamation: a multicentre UK case cohort study: the evaluation of a new topical therapy for the treatment and prevention of radiation­‑induced skin damage and moist desquamation. Journal of Radiotherapy in Practice. 2021;1-5. Go to original source...
  8. Barnea Y, Weiss J, Gur E. A review of the applications of the hydrofiber dressing with silver (Aquacel Ag) in wound care. Ther Clin Risk Manag. 2010;6:21-27. Go to original source...
  9. Paterson D, Poonam P, Bennett NC, et al. Randomized Intra­‑patient Controlled Trial of Mepilex Lite Dressings versus Aqueous Cream in Managing Radiation­‑Induced Skin Reactions Postmastectomy. Journal of Cancer Science & Therapy. 2012;04(11). DOI: 10.4172/1948-5956.1000166. Go to original source...
  10. Suresh R, Raffi J, Yuen F, et al. Treatment of moist desquamation for patients undergoing radiotherapy. International Journal of Women's Dermatology. 2019;5(2):124-125. Go to original source... Go to PubMed...




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.